Downloadable Materials

These materials are intended to help you understand more about cystic fibrosis (CF) and treatment with KALYDECO® (ivacaftor).

For Healthcare Professionals: Delivering KALYDECO to Patients as Young as 4 Months1 

Download this brochure for an overview of clinical trial data in patients with CF age 4 to 24 months with ivacaftor-responsive CFTR mutations

For Your Patients: A Guide to KALYDECO for Patients and Caregivers

Download this brochure for details about KALYDECO in patients age 4 to 24 months, including information on how it works, how it was studied, and how it's taken